These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16253810

  • 1. Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer.
    Bryan JN, Jia F, Mohsin H, Sivaguru G, Miller WH, Anderson CJ, Henry CJ, Lewis MR.
    Nucl Med Biol; 2005 Nov; 32(8):851-8. PubMed ID: 16253810
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy.
    Bryan JN, Jia F, Mohsin H, Sivaguru G, Anderson CJ, Miller WH, Henry CJ, Lewis MR.
    Cancer Biol Ther; 2011 Jun 15; 11(12):1001-7. PubMed ID: 21464612
    [Abstract] [Full Text] [Related]

  • 3. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR, Wang M, Axworthy DB, Theodore LJ, Mallet RW, Fritzberg AR, Welch MJ, Anderson CJ.
    J Nucl Med; 2003 Aug 15; 44(8):1284-92. PubMed ID: 12902420
    [Abstract] [Full Text] [Related]

  • 4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.
    J Nucl Med; 2004 Oct 15; 45(10):1776-83. PubMed ID: 15471848
    [Abstract] [Full Text] [Related]

  • 5. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 6. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.
    Rossin R, Pan D, Qi K, Turner JL, Sun X, Wooley KL, Welch MJ.
    J Nucl Med; 2005 Jul 15; 46(7):1210-8. PubMed ID: 16000291
    [Abstract] [Full Text] [Related]

  • 7. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ, Bleichrodt RP, Soede AC, Verhofstad AA, Goldenberg DM, Oyen WJ, Boerman OC.
    J Nucl Med; 2004 Jul 15; 45(7):1224-32. PubMed ID: 15235070
    [Abstract] [Full Text] [Related]

  • 8. Development of a two-antibody model for the evaluation of copper-64 radioimmunotherapy.
    Bryan JN, Lewis MR, Henry CJ, Owen NK, Zhang J, Mohsin H, Jia F, Sivaguru G, Anderson CJ.
    Vet Comp Oncol; 2004 Jun 15; 2(2):82-90. PubMed ID: 19379188
    [Abstract] [Full Text] [Related]

  • 9. Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
    Sharkey RM, Brenner A, Burton J, Hajjar G, Toder SP, Alavi A, Matthies A, Tsai DE, Schuster SJ, Stadtmauer EA, Czuczman MS, Lamonica D, Kraeber-Bodere F, Mahe B, Chatal JF, Rogatko A, Mardirrosian G, Goldenberg DM.
    J Nucl Med; 2003 Dec 15; 44(12):2000-18. PubMed ID: 14660727
    [Abstract] [Full Text] [Related]

  • 10. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY, Chu DZ, Yamauchi D, Odom-Maryon TL, Williams LE, Liu A, Esteban JM, Wu AM, Primus FJ, Beatty JD, Shively JE, Raubitschek AA.
    J Nucl Med; 1998 Dec 15; 39(12):2097-104. PubMed ID: 9867150
    [Abstract] [Full Text] [Related]

  • 11. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
    Lahorte CM, Bacher K, Burvenich I, Coene ED, Cuvelier C, De Potter C, Thierens H, Van de Wiele C, Dierckx RA, Slegers G.
    J Nucl Med; 2004 Jun 15; 45(6):1065-73. PubMed ID: 15181142
    [Abstract] [Full Text] [Related]

  • 12. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y, Zhang X, Xiong Z, Cheng Z, Fisher DR, Liu S, Gambhir SS, Chen X.
    J Nucl Med; 2005 Oct 15; 46(10):1707-18. PubMed ID: 16204722
    [Abstract] [Full Text] [Related]

  • 13. Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
    Stein R, Govindan SV, Chen S, Reed L, Richel H, Griffiths GL, Hansen HJ, Goldenberg DM.
    J Nucl Med; 2001 Jun 15; 42(6):967-74. PubMed ID: 11390564
    [Abstract] [Full Text] [Related]

  • 14. Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.
    Lewis MR, Boswell CA, Laforest R, Buettner TL, Ye D, Connett JM, Anderson CJ.
    Cancer Biother Radiopharm; 2001 Dec 15; 16(6):483-94. PubMed ID: 11789025
    [Abstract] [Full Text] [Related]

  • 15. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM, Beaumier P, Axworthy D, Atcher R, Fritzberg A.
    Nucl Med Biol; 2005 Oct 15; 32(7):741-7. PubMed ID: 16243650
    [Abstract] [Full Text] [Related]

  • 16. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR, Visser GW, Vosjan MJ, Stigter-van Walsum M, Tijink BM, Leemans CR, van Dongen GA.
    J Nucl Med; 2005 Nov 15; 46(11):1898-906. PubMed ID: 16269605
    [Abstract] [Full Text] [Related]

  • 17. Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu.
    Mohsin H, Jia F, Sivaguru G, Hudson MJ, Shelton TD, Hoffman TJ, Cutler CS, Ketring AR, Athey PS, Simón J, Frank RK, Jurisson SS, Lewis MR.
    Bioconjug Chem; 2006 Nov 15; 17(2):485-92. PubMed ID: 16536481
    [Abstract] [Full Text] [Related]

  • 18. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.
    Förster GJ, Santos EB, Smith-Jones PM, Zanzonico P, Larson SM.
    J Nucl Med; 2006 Jan 15; 47(1):140-9. PubMed ID: 16391198
    [Abstract] [Full Text] [Related]

  • 19. Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
    Lewis MR, Zhang J, Jia F, Owen NK, Cutler CS, Embree MF, Schultz J, Theodore LJ, Ketring AR, Jurisson SS, Axworthy DB.
    Nucl Med Biol; 2004 Feb 15; 31(2):213-23. PubMed ID: 15013487
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
    Shankar S, Vaidyanathan G, Affleck DJ, Peixoto K, Bigner DD, Zalutsky MR.
    Nucl Med Biol; 2004 Oct 15; 31(7):909-19. PubMed ID: 15464393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.